All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

General Medicine

Carvykti

(ciltacabtagene autoleucel)

Uses, side effects, dosage information & price range

Janssen-Cilag International NV

About this medicine

Carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least one prior therapy, including an immunomodulatory agent and a proteasome inhibitor have demonstrated disease progression on the last therapy, and are refractory to lenalidomide.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

JascaydComposition: nerandomilastBoehringer Ingelheim International GmbH
Price on RequestView Details →
PaxlovidComposition: nirmatrelvir;ritonavirPfizer Europe MA EEIG
Price on RequestView Details →
CenrifkiComposition: tolebrutinibSanofi Winthrop Industrie
Price on RequestView Details →
MyqorzoComposition: aficamtenCytokinetics (Ireland) Limited
Price on RequestView Details →
Trabectedin AccordComposition: trabectedinAccord Healthcare S.L.U.
Price on RequestView Details →

Key Information

Salt / Composition

ciltacabtagene autoleucel

Category

General Medicine

Manufacturer

Janssen-Cilag International NV

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.